Physician profile
Michael S Le
NPI 1427382985
$967.81
in general payments reported to CMS, 2019-2025
17 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2021: $79.08 · 2022: $227 · 2023: $51.46 · 2024: $71.60 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $289.05 | 2019-2022 | |
| Abbvie INC. | $169.54 | 2019-2025 | |
| Janssen Biotech, INC. | $89.78 | 2021-2022 | |
| Cook Medical LLC | $78.86 | 2019 | |
| Lilly USA, LLC | $54.66 | 2025 | Omvoh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.34 | 2021-2022 | |
| Ardelyx, INC. | $44.98 | 2024-2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $28.76 | 2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $25.34 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $25.14 | 2025 | Dupixent |
| Olympus America INC. | $22.08 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.43 | 2022 | |
| Pfizer INC. | $16.64 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.63 | 2019 | |
| Qol Medical, LLC | $13.26 | 2023 | Sucraid |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $13.21 | 2019 | |
| Medtronic, INC. | $13.11 | 2024 | Gi Genius |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.